Clinical Trial Update: Pharmacodynamics and Pharmacokinetics of Citalopram and Escitalopram [Phase 1]

View source ↗

Summary

Phase 1 pharmacodynamics and pharmacokinetics data for the antidepressants citalopram and escitalopram were reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Celexa (citalopram) (citalopram)
• Lexapro (escitalopram) (escitalopram)

Snippet

Sponsor: Mayo Clinic | Conditions: Depression | Phase 1 | Status: COMPLETED